ACT AMYLYX CARE TEAM
Live / Registered — Registered (as of 19 Nov 2024)
What this means for you
Registered since 19 Nov 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97978760
- Registration number
- 7573822
- Mark type
- Design + words
- Filed
- 15 Aug 2022
- Published for opposition
- 18 Jul 2023
- Registered
- 19 Nov 2024
- Attorney of record
- Cynthia Johnson Walden
Goods and services
- Class 044 — Medical, beauty and agricultural services: Consulting services in the field of medical patient care and medical services
- Class 045 — Legal and security services: Providing patient advocate and case management services, namely, coordinating the procurement, administration, and delivery of medication for patients undergoing medical treatment; Providing patient advocate and case management services, namely, patient personal advocacy services to meet the needs of patients undergoing medical treatment
Owner
- Amylyx Pharmaceuticals, Inc., Cambridge, MA, US
- Amylyx Pharmaceuticals, Inc., Cambridge, MA, US
- Amylyx Pharmaceuticals, Inc., Cambridge, MA, US
Prosecution history
- 23 Feb 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 23 Feb 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 23 Feb 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 23 Feb 2026 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 23 Feb 2026 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 19 Nov 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 19 Nov 2024 — REGISTERED-PRINCIPAL REGISTER
- 10 Oct 2024 — ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
- 04 Oct 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 04 Oct 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 06 Sept 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 04 Apr 2024 — USE AMENDMENT FILED
- 06 Sept 2024 — DIVISIONAL PROCESSING COMPLETE
- 12 Mar 2024 — DIVISIONAL REQUEST RECEIVED
- 04 Apr 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED